Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

HTTPS

Secure .gov websites use HTTPS
A lock (LockA locked padlock) or https:// means you have safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • Environmental Topics
  • Laws & Regulations
  • Report a Violation
  • About EPA
Contact Us

Grantee Research Project Results

Partitioning and Accumulation of Selected Basic Pharmaceuticals in Natural Organic Matrices

EPA Grant Number: F07E10138
Title: Partitioning and Accumulation of Selected Basic Pharmaceuticals in Natural Organic Matrices
Investigators: Fallert, Kari L.
Institution: Oklahoma State University
EPA Project Officer: Lee, Sonja
Project Period: January 1, 2007 through January 1, 2010
RFA: STAR Graduate Fellowships (2007) RFA Text |  Recipients Lists
Research Category: Fellowship - Aquatic Ecology and Ecosystems , Academic Fellowships , Fellowship - Aquatic Systems Ecology

Objective:

Although partitioning coefficients such as water-sediment and octanol-water are commonly used to evaluate environmental fate of chemical contaminants, limited previous research has examined differential partitioning between various types of organic matter found in streams. This study will examine the partitioning of a series of environmental contaminants, with specific emphasis on basic pharmaceuticals, to various natural matrices, including fine particulate organic matter (FPOM), coarse particulate organic matter (CPOM), sediment, periphyton, and aquatic biofilm. If differential partitioning occurs, potential implications include: matrices which have the highest degree of partitioning could be used as biomarkers during environmental assessments, remediation techniques could be improved, and assessment of exposure may be enhanced. In addition, the mechanism of differential sorption will be examined including the possibility that a combination of sorption mechanisms, such as cation exchange and hydrophilic-hydrophobic interactions, are responsible.

Approach:

A series of basic pharmaceuticals, that are potential environmental contaminants, will be evaluated including propranolol, ciprofloxacin, sertraline, and nicotine. Partitioning of the compounds between water and environmental matrices will be determined utilizing batch experiments with a variety of matrices that occur in aquatic systems. Initial studies will utilize leaf discs for the CPOM, amphipod processed leaf material for FPOM, and biofilm collected on glass beads placed within natural aquatic systems. Secondary studies will collect matrices from stream and wetland sites.

Radiolabeled compounds (14C and 3H), when available, will be used to quantify the amount of analyte in both aqueous and solid matrices. Otherwise, extraction and chromatographic analysis will be conducted. Partitioning coefficients will then be calculated. Several secondary factors such as the influence of concentration and pH will be evaluated. In order to determine the primary mechanism of sorption and if mixed mechanisms of sorption increase partitioning, the affinity of each compound to cation exchange resins and octanol (KOW) will be determined.

Expected Results:

Based on preliminary data, it appears differential sorption among matrices is likely. Our hypothesis is that the effect will be greatest for weak organic bases, moderate for polar organics, and limited for nonpolar organics. Since many pharmaceuticals are weak bases, differential partitioning is likely to be a major factor in the fate assessment of many classes of pharmaceuticals. Overall, this research will provide an initial assessment of the degree of differential partitioning that may occur among aquatic matrices and whether more detailed partitioning estimates are necessary to adequately assess the risk of organic contaminants.

Supplemental Keywords:

Fate; Bioassessment; Partitioning; FPOM; CPOM; Biofilm; Pharmaceuticals,

Progress and Final Reports:

  • 2007
  • 2008
  • Final
  • Top of Page

    The perspectives, information and conclusions conveyed in research project abstracts, progress reports, final reports, journal abstracts and journal publications convey the viewpoints of the principal investigator and may not represent the views and policies of ORD and EPA. Conclusions drawn by the principal investigators have not been reviewed by the Agency.

    Site Navigation

    • Grantee Research Project Results Home
    • Grantee Research Project Results Basic Search
    • Grantee Research Project Results Advanced Search
    • Grantee Research Project Results Fielded Search
    • Publication search
    • EPA Regional Search

    Related Information

    • Search Help
    • About our data collection
    • Research Grants
    • P3: Student Design Competition
    • Research Fellowships
    • Small Business Innovation Research (SBIR)
    Contact Us to ask a question, provide feedback, or report a problem.
    Last updated April 28, 2023
    United States Environmental Protection Agency

    Discover.

    • Accessibility
    • Budget & Performance
    • Contracting
    • EPA www Web Snapshot
    • Grants
    • No FEAR Act Data
    • Plain Writing
    • Privacy
    • Privacy and Security Notice

    Connect.

    • Data.gov
    • Inspector General
    • Jobs
    • Newsroom
    • Open Government
    • Regulations.gov
    • Subscribe
    • USA.gov
    • White House

    Ask.

    • Contact EPA
    • EPA Disclaimers
    • Hotlines
    • FOIA Requests
    • Frequent Questions

    Follow.